User profiles for Ying Yang

Ying-Wei Yang

- Verified email at jlu.edu.cn - Cited by 22474

Ying Yang

- Verified email at unr.edu - Cited by 2963

[PDF][PDF] Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases

…, H Yang, Y Liu, Y Yang, P Wang, SH Kim, S Ito, C Yang… - Cancer cell, 2011 - cell.com
IDH1 and IDH2 mutations occur frequently in gliomas and acute myeloid leukemia, leading
to simultaneous loss and gain of activities in the production of α-ketoglutarate (α-KG) and 2-…

Self-healing polymeric materials

Y Yang, MW Urban - Chemical Society Reviews, 2013 - pubs.rsc.org
Inspired by nature, self-healing materials represent the forefront of recent developments in
materials chemistry and engineering. This review outlines the recent advances in the field of …

Dynamic transcriptomic m6A decoration: writers, erasers, readers and functions in RNA metabolism

Y Yang, PJ Hsu, YS Chen, YG Yang - Cell research, 2018 - nature.com
N 6 -methyladenosine (m 6 A) is a chemical modification present in multiple RNA species,
being most abundant in mRNAs. Studies on enzymes or factors that catalyze, recognize, and …

N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO

…, Y Yang, C Yi, T Lindahl, T Pan, YG Yang… - Nature chemical …, 2011 - nature.com
We report here that fat mass and obesity-associated protein (FTO) has efficient oxidative
demethylation activity targeting the abundant N6-methyladenosine (m 6 A) residues in RNA in …

5-methylcytosine promotes mRNA export—NSUN2 as the methyltransferase and ALYREF as an m5C reader

X Yang, Y Yang, BF Sun, YS Chen, JW Xu, WY Lai, A Li… - Cell research, 2017 - nature.com
5-methylcytosine (m 5 C) is a post-transcriptional RNA modification identified in both stable
and highly abundant tRNAs and rRNAs, and in mRNAs. However, its regulatory role in …

[HTML][HTML] Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment

LTH Phi, IN Sari, YG Yang, SH Lee, N Jun… - Stem cells …, 2018 - hindawi.com
Cancer stem cells (CSCs), also known as tumor-initiating cells (TICs), are suggested to be
responsible for drug resistance and cancer relapse due in part to their ability to self-renew …

Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein

MM Ollmann, BD Wilson, YK Yang, JA Kerns, Y Chen… - Science, 1997 - science.org
Expression of Agouti protein is normally limited to the skin where it affects pigmentation, but
ubiquitous expression causes obesity. An expressed sequence tag was identified that …

Metal–organic framework (MOF)‐based drug/cargo delivery and cancer therapy

MX Wu, YW Yang - Advanced Materials, 2017 - Wiley Online Library
Metal–organic frameworks (MOFs)—an emerging class of hybrid porous materials built from
metal ions or clusters bridged by organic linkers—have attracted increasing attention in …

Is breast cancer survival improving? Trends in survival for patients with recurrent breast cancer diagnosed from 1974 through 2000

…, AU Buzdar, TL Smith, SW Kau, Y Yang… - … Journal of the …, 2004 - Wiley Online Library
BACKGROUND Despite advances in therapies for breast cancer, improvement in survival
for patients with recurrent or metastatic breast cancer has been difficult to establish. The …

Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase

…, YL Zhao, X Wang, JMR Danielsen, F Liu, YG Yang - Cell research, 2014 - nature.com
The methyltransferase like 3 (METTL3)-containing methyltransferase complex catalyzes the
N6-methyladenosine (m6A) formation, a novel epitranscriptomic marker; however, the …